Jennison Associates
INSP icon

Jennison Associates’s Inspire Medical Systems INSP Stock Holding History

Jennison Associates’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,439
Closed -$5.9M – 609
2025
Q2 		$5.9M Sell
45,439
-21,163
-32% -$3.07M ﹤0.01% 404
2025
Q1 		$10.6M Buy
66,602
+19,016
+40% +$3.44M 0.01% 378
2024
Q4 		$8.82M Buy
+47,586
New +$9.24M 0.01% 400
2024
Q3 		– Sell
-9,104
Closed -$1.22M – 590
2024
Q2 		$1.22M Sell
9,104
-248,750
-96% -$47.1M ﹤0.01% 473
2024
Q1 		$55.4M Sell
257,854
-47,032
-15% -$9.22M 0.04% 196
2023
Q4 		$62M Buy
304,886
+264,139
+648% +$42.8M 0.05% 168
2023
Q3 		$8.09M Sell
40,747
-51,671
-56% -$13M 0.01% 384
2023
Q2 		$30M Sell
92,418
-76,729
-45% -$21.9M 0.02% 264
2023
Q1 		$39.6M Buy
169,147
+408
+0.2% +$103K 0.04% 220
2022
Q4 		$42.5M Sell
168,739
-4,007
-2% -$854K 0.04% 209
2022
Q3 		$30.6M Buy
172,746
+13,810
+9% +$2.78M 0.03% 251
2022
Q2 		$29M Sell
158,936
-49,878
-24% -$9.95M 0.03% 257
2022
Q1 		$53.6M Buy
208,814
+1,588
+0.8% +$363K 0.04% 194
2021
Q4 		$47.7M Buy
207,226
+48,781
+31% +$11.9M 0.03% 227
2021
Q3 		$36.9M Sell
158,445
-21,487
-12% -$4.48M 0.02% 272
2021
Q2 		$34.8M Sell
179,932
-5,634
-3% -$1.12M 0.02% 284
2021
Q1 		$38.4M Sell
185,566
-23,799
-11% -$5.06M 0.03% 255
2020
Q4 		$39.4M Sell
209,365
-11,603
-5% -$1.9M 0.03% 247
2020
Q3 		$28.5M Sell
220,968
-1,497
-0.7% -$165K 0.02% 265
2020
Q2 		$19.4M Buy
+222,465
New +$17.1M 0.02% 301
2019
Q1 		– Sell
-75,081
Closed -$3.17M – 662
2018
Q4 		$3.17M Sell
75,081
-14,899
-17% -$633K ﹤0.01% 495
2018
Q3 		$3.79M Buy
89,980
+674
+0.8% +$31.6K ﹤0.01% 504
2018
Q2 		$3.19M Buy
+89,306
New +$2.88M ﹤0.01% 513

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates's INSP Position: Q3 2025 in Review

Jennison Associates sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 45,439 shares — an estimated $5.9M sold.

Jennison Associates first reported a position in INSP in Q2 2018 and held it in 23 quarters. The position peaked at $62M in Q4 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Jennison Associates reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Jennison Associates sold 45,439 Inspire Medical Systems shares in Q3 2025, an estimated $5.9M.
  • Jennison Associates first reported a position in Inspire Medical Systems in Q2 2018 and held it in 23 quarters.
  • Jennison Associates's Inspire Medical Systems position peaked at $62M in Q4 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.